article thumbnail

Off-label treatment for alcohol use disorder is linked to slower liver decline, study suggests

STAT

But a different medication, one frequently used off-label for the condition, could provide greater benefit to patients with alcohol-associated liver disease, a new study suggests.  Nearly 30 million adults in the United States have alcohol use disorder, according to the 2022 National Survey on Drug Use and Health. 

Labelling 139
article thumbnail

Bullish on growing use of telehealth, Wheel banks $150M to expand white-labeled virtual care services

Fierce Healthcare

Bullish on growing use of telehealth, Wheel banks $150M to expand white-labeled virtual care services. Wed, 01/19/2022 - 16:26.

Labelling 120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA blesses atopic dermatitis label expansions for Organon's Vtama, Galderma's Nemluvio

Fierce Pharma

On Monday, the agency signed off on Organons Vtama, a topical cream which was originally approved for plaque psoriasis in 2022. Vtamas label expansion came just three days after the FDA gave a thumbs up to Galdermas Nemluvio, which was previously endorsed by the FDA for prurigo nodularis.

article thumbnail

AbbVie's Vraylar, carrying $4B sales target, wins FDA label expansion in depression

Fierce Pharma

AbbVie's Vraylar, carrying $4B sales target, wins FDA label expansion in depression. Mon, 12/19/2022 - 11:13.

article thumbnail

15 Antibiotic Myths To Beware

IDStewardship

Article posted 27 October 2022. Myth 9: Penicillin allergy labels are not a big deal. Approximately 10% of the US adult population has a penicillin allergy label and only about 10% of those labels represent true allergies. In this article an infectious diseases pharmacist discusses antibiotic myths. Gauthier, Pharm.D.,

Labelling 364
article thumbnail

RFID: The future of smart labelling?

Pharmaceutical Technology

In August of 2022, Fresenius Kabi announced a three-year plan to add GS1 Data Matrix barcodes, also known as 2D barcodes, to its US pharmaceutical portfolio. What lies ahead for RFID and smart labelling Volpe says “the future is bright” for smart technologies that identify, monitor, and track medications through the supply chain.

Labelling 105
article thumbnail

Heart failure: clinical trials update 2022

European Pharmaceutical Review

The American Heart Association (AHA)’s Scientific Sessions 2022 is a global exchange of the latest advancements in research and clinical practice of cardiovascular science. The results were shared at the American Heart Association’s 2022 Scientific Sessions and published in the Lancet. Hypertension. August 2021.

Labelling 118